Primary drug resistance and transmission analysis of HIV-1 in acute and recent drug-naive seroconverters in Singapore

被引:25
|
作者
Lee, C. C.
Sun, Y. J. [1 ]
Barkham, T. [2 ]
Leo, Y. S.
机构
[1] Tan Tock Seng Hosp, TTSH Med Ctr, Infect Dis Res Lab, Dept Infect Dis, Singapore 308433, Singapore
[2] Tan Tock Seng Hosp, Dept Lab Med, Singapore 308433, Singapore
基金
英国医学研究理事会;
关键词
HIV-1; molecular epidemiology; phylogenetics; primary resistance; seroconverter; IMMUNODEFICIENCY-VIRUS TYPE-1; TREATMENT-EXPERIENCED PATIENTS; HETEROSEXUAL TRANSMISSION; MOLECULAR EPIDEMIOLOGY; ANTIRETROVIRAL THERAPY; GENOTYPIC RESISTANCE; PRIMARY INFECTION; VIRAL LOAD; MUTATIONS; RISK;
D O I
10.1111/j.1468-1293.2009.00698.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives The aim of the study was to elucidate primary drug resistance and transmission of HIV-1 in acute and recent drug-naive seroconverters in Singapore. Methods Acute and recent HIV-1 seroconverters were enrolled in the study. The HIV-1 polymerase (pol) gene was sequenced and used for genotypic drug resistance analysis and phylogenetic analysis. HIV-1 transmission clusters were inferred from phylogenetic clustering analysis. Results Of the 60 subjects analysed, 95% were men, and 73.3% were men who have sex with men (MSM). Six HIV-1 subtypes were identified, including CRF01_AE (46.7%), subtypes B (30%), B' (15%) and G (1.7%), CRF33_01B (1.7%) and CRF34_01B (5%). Primary genotypic resistance was detected in only one (1.7%) subtype B variant. Thirty-one patients (51.7%) were phylogenetically clustered, of whom 90% reported having local risk exposure, compared with 59% of the patients who were not phylogenetically clustered [odds ratio (OR) 6.35, 95% confidence interval (CI) 1.65-23.95]. MSM (OR 5.63, 95% CI 1.17-27.15), high viral load (OR 4.28, 95% CI 1.37-13.36) and young age (OR 0.92, 95% CI 0.85-0.99) were independently associated with clustered individuals. Conclusions In Singapore, HIV-1 primary resistance is insignificant; individuals with seroconversion account for about half of onward transmission among recently infected seroconverters. MSM, high viral load and young age are factors that facilitate transmission. Early detection of these individuals is of paramount importance for the prevention of HIV-1 transmission.
引用
收藏
页码:370 / 377
页数:8
相关论文
共 50 条
  • [21] Genetic heterogeneity of HIV-1 protease in drug-naive and drug-treated HIV-positive patients
    Ceccherini-Silberstein, F
    Bertoli, A
    Forbici, F
    Erba, F
    Balotta, C
    Giannella, S
    D'Arrigo, R
    Bellocchi, MC
    Gori, C
    Trotta, MP
    Monforte, AD
    Antinori, A
    Perno, CF
    [J]. ANTIVIRAL THERAPY, 2002, 7 : S179 - S179
  • [22] Detection of minor populations of drug-resistant HIV-1 in acute seroconverters
    Metzner, KJ
    Rauch, P
    Walter, H
    Boesecke, C
    Zöllner, B
    Jessen, H
    Schewe, K
    Fenske, S
    Gellermann, H
    Stellbrink, H
    [J]. AIDS, 2005, 19 (16) : 1819 - 1825
  • [23] Detection of minor populations of drug-resistant HIV-1 in acute seroconverters
    Metzner, KJ
    Rauch, P
    Walter, H
    Boesecke, C
    Zöllner, B
    Jessen, H
    Schewe, K
    Fenske, S
    Gellermann, H
    Stellbrink, HJ
    [J]. ANTIVIRAL THERAPY, 2005, 10 (04) : S123 - S123
  • [24] Transmitted drug resistance in drug-naive HIV-2 infected patients
    Duarte, Frederico
    Miranda, Ana Claudia
    Peres, Susana
    Diogo, Isabel
    Goncalves, Fatima
    Carvalho, Ana Patricia
    Costa, Ines
    Cabanas, Joaquim
    Moneti, Virginia
    Alves, Joao Vaz
    de Abreu, Ricardo Correia
    Neves, Isabel
    Aldir, Isabel
    Mansinho, Kamal
    Gomes, Perpetua
    [J]. AIDS, 2016, 30 (10) : 1687 - 1688
  • [25] HIV-1 viral load, phenotype, and resistance in a subset of drug-naive participants from the Delta trial
    BrunVezinet, F
    Boucher, C
    Loveday, C
    Descamps, D
    Fauveau, V
    Izopet, J
    Jeffries, D
    Kaye, S
    Krzyanowski, C
    Nunn, A
    Schuurman, R
    Seigneurin, JM
    Tamalet, C
    Tedder, R
    Weber, J
    Weverling, GJ
    Aber, V
    Aboulker, JP
    Babiker, AG
    Bragman, K
    Breckenridge, AM
    Carbon, C
    Charreau, I
    Chene, G
    Collis, P
    Cooper, D
    Darbyshire, JH
    Dormont, J
    Fiddian, P
    Flepp, M
    Gazzard, B
    Goebel, FD
    Hooker, M
    Lange, J
    Luthy, R
    Peto, TEA
    Reiss, P
    Seligmann, M
    Stone, AB
    Thomis, J
    Vella, S
    Walckenaer, G
    Warrell, D
    Weller, IVD
    Wilber, R
    Yeni, P
    Yeo, J
    Withnall, R
    Babiker, A
    Bloch, J
    [J]. LANCET, 1997, 350 (9083): : 983 - 990
  • [26] Primary HIV-1 drug resistance in Brazil
    Soares, MA
    Brindeiro, RM
    Tanuri, A
    [J]. AIDS, 2004, 18 : S9 - S13
  • [27] Prevalence of HIV-1 primary drug resistance in seroconverters of the ICoNA cohort over the period 1996-2001
    Violin, M
    Velleca, R
    Cozzi-Lepri, A
    Riva, C
    Grossi, PA
    Carnevale, G
    Rizzardini, G
    Petrelli, E
    Perno, CF
    Monforte, AD
    Balotta, C
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 36 (02) : 761 - 764
  • [28] Surveillance of HIV-1 pol transmitted drug resistance in acutely and recently infected antiretroviral drug-naIve persons in rural western Kenya
    Onywera, Harris
    Maman, David
    Inzaule, Seth
    Auma, Erick
    Were, Kennedy
    Fredrick, Harrison
    Owiti, Prestone
    Opollo, Valarie
    Etard, Jean-Francois
    Mukui, Irene
    Kim, Andrea A.
    Zeh, Clement
    [J]. PLOS ONE, 2017, 12 (02):
  • [29] HIV-1 pol gene polymorphism and antiretroviral resistance mutations in drug-naive pregnant women in Yaounde, Cameroon
    Vessière, A
    Nerrienet, E
    Kfutwah, A
    Menu, E
    Tejiokem, M
    Pinson-Recordon, P
    Barré-Sinoussi, FO
    Fleury, H
    Ayouba, A
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 42 (02) : 256 - 258
  • [30] HfV-1 transmission dynamics in recent seroconverters:: relationship with transmission of drug resistance and viral diversity
    Recordon-Pinson, P.
    Peuchant, O.
    Captlepont, S.
    Lavignolle, V.
    Neau, D.
    Morlat, P.
    Pellegrin, J. L.
    Thiébaut, R.
    Dabis, F.
    Fleury, H.
    Masquelier, B.
    Cohort, A. N. R. S. C. Aquitaine
    [J]. ANTIVIRAL THERAPY, 2007, 12 : S43 - S43